Nordmann at CPHI Frankfurt 2025, Booth 8Q57
A key topic at this year's trade fair is the global changes that are increasingly affecting the pharmaceutical supply chain.
“The world is in flux. There are numerous macroeconomic challenges facing the market. Many pharmaceutical companies are considering to repositioning themselves in light of the new customs agreements from the US. In addition, there is an increasing offer of raw materials for APIs and excipients from India. These are not exactly quiet times...,” comments Dr. Ulla Seidel, Global Sales Director Life Sciences at Nordmann, adding: “However, our customers attach great importance to stable, sustainable supply security. That is why it is important for us at Nordmann to focus clearly on trusting, long-term partnerships such as the one we have with our co-exhibitor Mingtai. Stable, resilient supply chains with our partners are more important than ever today so that we can serve our customers reliably and centrally.”
Dr. Ulla Seidel, Global Sales Director Life Sciences
As a co-exhibitor, Mingtai will be showcasing its expertise in the manufacture of highly functional ingredients such as COMPRECEL® SMCC, a silicified microcrystalline cellulose that solves complex formulation problems and is ideal for direct compression, dry granulation, and MUPS (Multiple Unit Pellet System) formulations. Mingtai will also be presenting its vision for a greener future: “We look forward to exchanging ideas on new technologies and sustainable solutions,” says Richer Chen, Chairman & President of Mingtai. “Our new EXCiPACT-certified production facility in Hukou Township stands for environmentally friendly architecture, optimized processes, and modern equipment – an active contribution to a more sustainable future and the positive development of the region.”
Franziska Steller, Business Manager Health Care at Nordmann Germany, also sees clear trends: “The demand for innovative, sustainably produced ingredients for AI supported drug research or production is growing rapidly. Our customers are looking for individual solutions – and for partners like us who can serve them professionally and competently.”
Franziska Steller, Business Manager Health Care
In addition to Mingtai, Nordmann is presenting other strong partners with their products:
- BioSpectra: Full cGMP-compliant portfolio of biological buffers, excipients and process chemicals for the biotech and biopharma industry – now distributed by Nordmann in Germany, Italy, Japan, and the Nordic countries.
- Cell Biotech: Double-layer tablet with patented LAB2PRO™ double coating technology – an advanced and flexible solution specifically designed for the manufacture of probiotic drugs, combining different release patterns with the ability to safely administer incompatible active ingredients.
- Ingredion: The UNI-PURE® range consists of pharmaceutical-grade corn/maize starches, infant formular starches, MANNITABTM to be used as fillers and binders for oral dosage forms.
- IOI Oleo: MIGLYOL® and IMWITOR® for pharmaceutical formulations – from infusions to chewable tablets. The products are characterized by their high purity, natural origin, and versatile dosage forms.
- WACKER: Pyrogenic silica HDK® and silicone-based SILFAR® antifoaming agents with excellent technical properties for pharmaceutical applications. Focus on sustainability and the goal of climate neutrality by 2045.
Visitors can find Nordmann at CPHI Frankfurt 2025 from October 28 to 30 at booth Q57 in hall 8.
For more information, please contact:
